Executive Vice President,
BioInvent International AB
Dr Cristina Glad is Executive Vice President at BioInvent International AB, Lund, Sweden. Dr Glad has worked within the BioInvent group since 1987 inter alia as Director of Manufacturing and Business Development from 1990 to 1997 and held thereafter until the merger on November 1, 2002 between BioInvent International AB and its subsidiaries the position as President of BioInvent Production AB.
Before joining BioInvent, Dr Glad acted as a Consultant and a visiting Research Fellow at BioInvent from 1984 to 1986. Dr Glad was previously an Assistant Professor at the Department of Biotechnology, Lund University, Lund, Sweden (1983 to 1986). She received a M.Sc. degree in Chemical Engineering from Lund Institute of Technology, Lund, Sweden, and her D.Sc. degree in Biochemistry from Lund University, Lund, Sweden in 1981. She also holds an MBA from Scandinavian International Management Institute, Copenhagen, Denmark 1998.
- Challenges to develop and grow a biotech company - the BioInvent case ( 3.25 MB)
To develop and grow a biotech drug-developing company requires skills to build a sustainable portfolio of innovative drug projects. Important elements is internal R&D competence that collaborate with internationally-recognised academic groups and leading industrial partners and a business model that can meet the financial challenges that lies in the long development time lines in drug development.